Čes-slov Pediat 2025, 80(4):195-196 | DOI: 10.55095/CSPediatrie2025/032
Advances in pediatric antituberculosis therapy: toward child-friendly all-in-one dosage forms
- Pediatrická klinika, 1. lékařská fakulta, Univerzita Karlova a Fakultní Thomayerova nemocnice, Praha
Contemporary pharmaceutical agents, specifically orodispersible tablets, are now entering the management of tuberculosis in children. The pharmaceuticals are available in two forms: either in combination (isoniaside+rifampicin+pyrazinamide, isoniazid+rifampicin) or as monotherapy (isoniaside, ethambutol). The treatment is primarily indicated for the youngest age groups.
Keywords: tuberculosis, treatment, oral dispersible all-in-one tablets
Accepted: June 5, 2025; Published: July 1, 2025 Show citation
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.